Laser-Assisted Microdissection (LAM) is a cutting-edge technology that allows for precise isolation and extraction of specific cells or tissue regions from complex biological samples under microscopic visualization. Employing a laser beam, LAM enables researchers to selectively dissect target cells or structures, preserving the integrity of the isolated material for subsequent molecular analysis. Widely used in genomics, proteomics, and molecular pathology, LAM finds applications in various fields, including cancer research, neuroscience, and developmental biology. This technology is particularly valuable for studying heterogeneous tissues where isolating distinct cell populations is essential. LAM facilitates single-cell analysis, enabling researchers to explore the molecular characteristics and heterogeneity of individual cells within a tissue. The technique is pivotal in uncovering genetic and proteomic signatures associated with specific cell types or pathological conditions. Moreover, LAM allows for the isolation of rare cells, enhancing the sensitivity and specificity of downstream analyses. While LAM offers unparalleled precision, challenges include potential damage to the dissected material and the need for expertise in microscopic visualization and laser manipulation. Despite these challenges, Laser-Assisted Microdissection continues to be a powerful tool in advancing our understanding of complex biological systems and driving breakthroughs in personalized medicine and targeted therapies.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States